GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Chairman of the Board

Chief Executive Officer

SVP and General Counsel

VP Corporate Environment, Health and Safety

VP Employee Health Management

Framework

Issues

Performance

Verification statement

Index

Chief Executive Officer
Previous
Next
 
 
  Dr. JP Garnier

"Sustainability, by definition, is good for business, society and the environment. To be integrated into the way we do business, it must be driven from the top. That is why I take a personal interest in sustainability issues like finding a sustainable way to provide medicines to people with the most need and protecting the environment and the health and safety of our employees. This report is a companion to the CSR report and describes our programmes in environmental sustainability and our progress in 2002 toward our 2005 targets. Sustainability is a long term aspiration but we are making steady progress toward that goal. We will continue to build on what we have done and try to find innovative ways to progress the sustainability agenda."

Dr. JP Garnier


Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement